PathoQuest

PathoQuest is a France-based company that provides clinical diagnostics and biological quality control testing services for the biopharmaceutical industry.

Business Model:

Revenue: $10M

Employees: 11-50

Detailed PathoQuest Information

Geographic Data

PathoQuest headquarters map

Address: 11 rue Watt

City: Paris

State: île-de-france

Zip: 75013

Country: FR

Financial Info

Stage:

series b

Raised Last:

$17M

Raised Total:

$28M

Metrics

8,482,179Website Global Rank

303Website Monthly Traffic

Twitter Followers

Description

PathoQuest is a France-based company that provides clinical diagnostics and biological quality control testing services for the biopharmaceutical industry.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2019 Venture Round $0 Charles River Laboratories International
Careismatic Brands
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
Charles River Laboratories International
Careismatic Brands
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
3/2011 Series A 1 $2.8M Kurma Partners
Kurma Partners
5/2018 Venture Round $0 Aurinvest
Fraser
Idinvest Partners
Kurma Partners
Aurinvest
Fraser
Idinvest Partners
Kurma Partners
7/2015 Venture Round $0 Kurma Partners
Aurinvest
Idinvest Partners
Kurma Partners
Aurinvest
Idinvest Partners
11/2021 Series B $11.6M SHS Gesellschaft für Beteiligungsmanagement mbH
Turenne Groupe
Kurma Partners
Verve ventures
Eurazeo
Aurinvest
Charles River Laboratories
9/2019 Series A $8.8M Norgine Ventures
Kurma Partners
Idinvest
Charles River
investiere
7/2013 Series B $5M Idinvest Partners
Aurinvest
Kurma Life Science Partners
3/2011 Seed $2.8M
11/2021 Series B 8 $17.4M Verve Ventures
Turenne Capital
SHS Capital
Kurma Partners
Fraser
Eurazeo
Charles River Laboratories International
Agrinvest
Verve Ventures
Turenne Capital
SHS Capital
Kurma Partners
Fraser
Eurazeo
Charles River Laboratories International
Agrinvest
11/2021 Series B $0 Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
7/2013 Series B 3 $5M Kurma Partners
Idinvest Partners
Agrinvest
Kurma Partners
Idinvest Partners
Agrinvest
11/2021 Series B 7 $17.4M Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
Aurinvest
Charles River Laboratories International
Eurazeo
Kurma Partners
SHS Capital
Turenne Capital
Verve Ventures
9/2019 Venture Round 7 $8.9M Careismatic Brands
Charles River Laboratories International
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
Careismatic Brands
Charles River Laboratories International
Fraser
Idinvest Partners
Kurma Partners
Norgine Ventures
Verve Ventures
5/2018 Venture Round 4 $4.7M Aurinvest
Fraser
Idinvest Partners
Kurma Partners
Aurinvest
Fraser
Idinvest Partners
Kurma Partners
7/2015 Venture Round 3 $2.2M Kurma Partners
Kurma Partners
7/2013 Series B 3 $5M Kurma Partners
Kurma Partners
3/2011 Series A 1 $2.8M Kurma Partners
Kurma Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research